| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d668d7b7bf44821a0ccc9ec7fe60148e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9bfa8401352c3a7c560cd9881718dfb9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c72e516b1970642b155eeada9887cc2b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_85670a0ee0846831cf58786536906763 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-19 |
| filingDate |
2006-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cea5aa7b7435123e90676948017e75d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ffcf5739658a618d17cde66c63d3c06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ca6fc958296477383fa30406e99760c |
| publicationDate |
2007-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2007053952-A1 |
| titleOfInvention |
Platelet factor-4 (pf-4) analogs and their use |
| abstract |
The present invention concerns the discovery, synthesis and use of peptidic analogs derived from platelet factor-4 chemokine (PF-4) and their pharmaceutical compositions. These compounds and their pharmaceutical compositions are useful in treating diseases such as : angiogenic related disorders ; hematopoietic disorders in which the stimulation of proliferation of hematopoietic stem cells/precursors ; the protection of hematopoietic cells from chemotherapy related drugs and/or the inhibition of differentiation of hematopoietic precursors are needed ; coagulatory related disorders requiring the inhibition of heparine or the increase in anti-coagulant activated protein C. ; and inflammation related disorders. |
| priorityDate |
2005-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |